Antibodies : Engineering and Therapeutics

Antibodies, also called immunoglobulins, are large Y-shaped proteins which function to identify and help remove foreign antigens or targets such as viruses and bacteria. Antibodies are produced by specialized white blood cells called B lymphocytes (or B cells). When an antigen binds to the B-cell surface, it stimulates the B cell to divide and mature into a group of identical cells called a clone. The mature B cells, called plasma cells, secrete millions of antibodies into the bloodstream and lymphatic system. Every different antibody recognizes a specific foreign antigen. This is because the two tips of its “Y” are specific to each antigen, allowing different antibodies to bind to different foreign antigens.Antibodies are produced by the immune system in response to the presence of an antigen. Antigens are large molecules, usually proteins, on the surface of cells, viruses, fungi, bacteria, and some non-living substances such as toxins, chemicals, and foreign particles. Any substance capable of triggering an immune response is called an antigen. The antibody recognizes a unique molecule of the harmful agent, called an antigen, via the variable region.

Antibody engineering has become a well-developed discipline, encompassing discovery methods, production strategies, and modification techniques that have brought forth clinically investigated and marketed therapeutics. The realization of the long-standing goal of production of fully human monoclonal antibodies has focused intensive research on the clinical employment of this potent drug category.

  • Lymphocytes: Research and novel strategies
  • Genomic, metabolomic and proteomic advances in cancer immunotherapy
  • Genetics and epigenetics of the immune system
  • Antibody-targeted fusion proteins for cancer therapy
  • Antibodies as drugs: Immunological scaffolds as therapeutics
  • Antibody biology & engineering
  • Antibodies and infectious diseases
  • Monoclonal antibodies and organ cancers
  • Antibodies and neuroscience
  • Genomic, metabolomic and proteomic advances in cancer immunotherapy

Related Conference of Antibodies : Engineering and Therapeutics

June 29-July 01, 2017

8th European Immunology Conference

Madrid, Spain
July 03-04, 2017

9thAnnual Meeting on Immunology and Immunologist

Kuala Lumpur, Malaysia
July 12-13, 2017

3rd World Conference on Parasitology & Pathogenicity

Chicago, Illinois, USA
August 07-08, 2017

Annual Summit on HIV/AIDS, STDs & STIs

Beijing, China
September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
September 14-15, 2017

7th World Congress on Immunology

Amsterdam, Netherlands
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress

Las Vegas, Nevada, USA
November 09-10, 2017

2nd International Conference on Autoimmunity

Madrid, Spain
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE

Antibodies : Engineering and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in